BAUDAX BIO INC (BXRX)

US07160F4046 - Common Stock

0.1864  +0 (+0.59%)

After market: 0.17 -0.02 (-8.8%)

News Image
7 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time for a dive into the biggest pre-market stock movers as we check out all of the latest news traders need to know about on Friday!

News Image
7 months ago - InvestorPlace

Why Is Baudax Bio (BXRX) Stock Up 75% Today?

Although Baudax Bio saw significant interest because of its orphan drug designation, BXRX stock must climb a wall of worry.

News Image
8 months ago - Seeking Alpha

Baudax Bio files to sell 15M shares of common stock for holders. (NASDAQ:BXRX)

BXRX Baudax Bio files to sell 15M shares of common stock for holders. This prospectus relates to the offering and resale by Alumni Capital LP. This preliminary prospectus is not an offer...

News Image
8 months ago - Baudax Bio

Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock

MALVERN, Pa., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (NASDAQ: BXRX), a biotechnology company focused on...

News Image
8 months ago - Baudax Bio

Baudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

MALVERN, Pa., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (Nasdaq: BXRX), a biotechnology company focused on...

News Image
8 months ago - Baudax Bio

Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update

Transformative Period Led by Acquisition of TeraImmune Company to Prioritize Development of New TI-168 Treg Asset for Hemophilia A Continuing to...

News Image
9 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting off the day with a breakdown of all the biggest pre-market stock movers traders need to know about on Friday!

News Image
10 months ago - Seeking Alpha

Baudax Bio shares more than double after TeraImmune acquisition (NASDAQ:BXRX)

Baudax Bio (BXRX) said on Friday that it had acquired TeraImmune, a Treg research companyBXRX shares more than double, up +163.4%. Under the deal, TeraImmune's outstanding equity...

News Image
10 months ago - Baudax Bio

Baudax Bio Acquires TeraImmune, Inc.

TeraImmune, an Advanced Treg Research Company, headed by Yong Chan Kim, Ph D, brings an approved Treg IND to the Strong Development team from Baudax ...